News

CDC accepts RSV recommendations made by former vaccine panel
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
Zacks Investment Research on MSN10d
MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up.
The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...
MedPage Today on MSN11d
CDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV Shot
With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...
RSV vaccine access expanded to some people in their 50s, according to CDC website
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
Hosted on MSN11mon
You may want to skip fall RSV vaccine, CDC says. What to know ... - MSN
Studies presented to the CDC ACIP Work Group for RSV found both vaccines from fall 2023 may result in a slightly elevated risk of Guillain-Barré syndrome, a rare but serious condition.
U.S. CDC accepts the former vaccine panel's RSV recommendations
The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...